Perrigo Company plc [PRGO] vs Regencell Bioscience [RGC] Detailed Stock Comparison

Perrigo Company plc

NYSE
Loading...

Regencell Bioscience

NASDAQ
Loading...

TLDR: Quick Comparison Summary

Based on 19 vital metrics comparison: Perrigo Company plc wins in 6 metrics, Regencell Bioscience wins in 6 metrics, with 0 ties. Both stocks appear equally matched on key metrics.

View Metrics Details

Vital Metrics Comparison

MetricPerrigo Company plcRegencell BioscienceBetter
P/E Ratio (TTM)2,818.00N/AN/A
Price-to-Book Ratio0.691,050.00Perrigo Company plc
Debt-to-Equity Ratio86.480.01Regencell Bioscience
PEG Ratio-30.50N/AN/A
EV/EBITDA7.50-1,820.56Regencell Bioscience
Profit Margin (TTM)-1.85%0.00%Regencell Bioscience
Operating Margin (TTM)6.43%0.00%Perrigo Company plc
EBITDA Margin (TTM)6.43%N/AN/A
Return on Equity-1.32%-47.77%Perrigo Company plc
Return on Assets (TTM)3.26%-30.65%Perrigo Company plc
Free Cash Flow (TTM)$244.60M$-4.01MPerrigo Company plc
1-Year Return-19.83%8,341.18%Regencell Bioscience
Price-to-Sales Ratio (TTM)0.71N/AN/A
Enterprise Value$6.48B$7.27BRegencell Bioscience
EV/Revenue Ratio1.50N/AN/A
Gross Profit Margin (TTM)34.36%N/AN/A
Revenue per Share (TTM)$31N/AN/A
Earnings per Share (Diluted)$-0.43$-0.01Regencell Bioscience
Beta (Stock Volatility)0.482.15Perrigo Company plc
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

Perrigo Company plc vs Regencell Bioscience Stock Performance Analysis

Loading Price Chart...

Perrigo Company plc
Regencell Bioscience
Perrigo Company plc Stock Overview | Regencell Bioscience Stock Overview

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Perrigo Company plc-1.75%-2.60%-4.19%-18.51%-23.06%-16.35%
Regencell Bioscience-0.28%6.85%9.38%-76.08%2,828.57%10,938.46%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Perrigo Company plc-19.83%-42.90%-51.92%-86.48%-67.36%54.15%
Regencell Bioscience8,341.18%1,788.16%5,025.00%5,025.00%5,025.00%5,025.00%

News Based Sentiment: Perrigo Company plc vs Regencell Bioscience

Perrigo Company plc

News based Sentiment: MIXED

September presented a mixed bag for Perrigo, with strong analyst support and insider buying offset by a disruptive labor strike and a declining stock price. While the company reaffirmed its financial outlook, the ongoing dispute introduces significant uncertainty, making it a month of conflicting signals for investors.

View Perrigo Company plc News Sentiment Analysis

Regencell Bioscience

News based Sentiment: NEGATIVE

September brought a significant stock decline for Regencell Bioscience, coupled with persistent concerns about its lack of revenue, assets, and overall financial viability. The 'going concern' warning and negative analyst ratings highlight substantial risks for investors, making this a critical month in the company's narrative.

View Regencell Bioscience News Sentiment Analysis

Performance & Financial Health Analysis: Perrigo Company plc vs Regencell Bioscience

MetricPRGORGC
Market Information
Market Cap i$3.06B$7.27B
Market Cap CategoryMid capMid cap
10 Day Avg. Volume i1,589,850282,440
90 Day Avg. Volume i1,881,250286,047
Last Close$21.37$14.31
52 Week Range$21.03 - $30.93$0.09 - $83.60
% from 52W High-30.91%-82.88%
All-Time High$215.73 (Apr 06, 2015)$950.00 (May 30, 2025)
% from All-Time High-90.09%-98.49%
Growth Metrics
Quarterly Revenue Growth-0.01%N/A
Quarterly Earnings Growth-0.01%N/A
Financial Health
Profit Margin (TTM) i-0.02%0.00%
Operating Margin (TTM) i0.06%0.00%
Return on Equity (TTM) i-0.01%-0.48%
Debt to Equity (MRQ) i86.480.01
Cash & Liquidity
Book Value per Share (MRQ)$32.50$0.01
Cash per Share (MRQ)$3.30N/A
Operating Cash Flow (TTM) i$366.20M$-3,881,392
Levered Free Cash Flow (TTM) i$775.95M$-4,301,837
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend i$0.00N/A

Valuation & Enterprise Metrics Analysis: Perrigo Company plc vs Regencell Bioscience

MetricPRGORGC
Price Ratios
P/E Ratio (TTM) i2,818.00N/A
Forward P/E i7.14N/A
PEG Ratio i-30.50N/A
Price to Sales (TTM) i0.71N/A
Price to Book (MRQ) i0.691,050.00
Market Capitalization
Market Capitalization i$3.06B$7.27B
Enterprise Value i$6.48B$7.27B
Enterprise Value Metrics
Enterprise to Revenue i1.50N/A
Enterprise to EBITDA i7.50-1,820.56
Risk & Other Metrics
Beta i0.482.15
Book Value per Share (MRQ) i$32.50$0.01

Financial Statements Comparison: Perrigo Company plc vs Regencell Bioscience

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)PRGORGC
Revenue/Sales i$1.06BN/A
Cost of Goods Sold i$693.40MN/A
Gross Profit i$362.90MN/A
Research & Development i$22.00MN/A
Operating Income (EBIT) i$55.60MN/A
EBITDA i$139.30MN/A
Pre-Tax Income i$3.20MN/A
Income Tax i$3.70MN/A
Net Income (Profit) i$-8.40MN/A

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)PRGORGC
Cash & Equivalents i$409.90M$2.96M
Total Current Assets i$2.53B$8.11M
Total Current Liabilities i$1.07B$193,578
Long-Term Debt i$3.59B$25,934
Total Shareholders Equity i$4.36B$8.22M
Retained Earnings i$-2.26B$-21.62M
Property, Plant & Equipment i$1.08B$84,780

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)PRGORGC
Operating Cash Flow i$-9.20MN/A
Capital Expenditures i$-25.50MN/A
Free Cash Flow i$-90.00MN/A
Debt Repayment i$-8.80MN/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricPRGORGC
Shares Short i7.40M1.90M
Short Ratio i3.946.31
Short % of Float i0.06%0.02%
Average Daily Volume (10 Day) i1,589,850282,440
Average Daily Volume (90 Day) i1,881,250286,047
Shares Outstanding i136.43M13.01M
Float Shares i136.80M18.43M
% Held by Insiders i0.00%0.96%
% Held by Institutions i1.06%0.00%

Dividend Analysis & Yield Comparison: Perrigo Company plc vs Regencell Bioscience

MetricPRGORGC
Last 12-Month Dividend i$0.00N/A
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend i$0.63N/A
3-Year Avg Dividend Yield i0.81%N/A
3-Year Total Dividends i$1.88N/A
Ex-Dividend DateMar 07, 2024N/A